A phase I study of the safety and immunogenicity of MVA85A in healthy Gambian volunteers
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs MVA 85A (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 11 Feb 2007 New trial record.